We are two founders who left our own doctor's orders on the nightstand, and a team that already operates under your regulators

A gastroenterologist ordered Víctor an endoscopy in 3 months and a follow-up in 6. That paper order sat on his nightstand for almost a year.

Pablo was ordered a biopsy for a minor haematological issue, on floor 4 of the very clinic he was standing in. A call came in, he had to leave, and none of it got done. Luckily, nothing serious.

Neither of us is a careless patient. Both of us had the order in hand, the money to pay for it and the clinic next door. What was missing was somebody writing back.

When we went looking at why this happens at scale, we found that the system does the hard part well and drops the easy one. The doctor writes the order, it is recorded in the chart, and there it stops: nobody owns the job of chasing it. The network gains a patient every time somebody does, and loses one every time nobody does.

Why should a new team touch your patients' records?

The same team runs SignatureAPI, an electronic-signature platform used today by Chilean and LatAm healthcare companies, among them medical-record and telehealth software. That means we already handle sensitive Chilean patient data under Ley 19.628, with customers who answer to the same regulators you do.

In the United States, that same platform signs BAAs under HIPAA for customers who require them, and among those customers is a CMS prime contractor, CMS being the agency that runs Medicare, operating under FISMA, the US federal information-security regime.

The regimes this team's software already runs under, with no customer names because several sit under confidentiality agreements:

• Healthcare in Chile: sensitive patient data, with Chilean medical-record and telehealth companies.
• Healthcare in the United States: HIPAA, with BAAs signed on customer request.
• US federal contracting: a CMS prime under FISMA.
• Regulated finance in Chile and other markets, where every signature has to be reconstructable years later.

Those certifications belong to SignatureAPI. Surface is being built to the same standard and does not yet carry audits of its own. Saying it the other way round is exactly the detail a compliance team finds on its own by the second meeting.

How many institutions use Surface today?

None we can name. We are in conversations and pilots with Chilean clinics, and our agreement with the first one keeps us from using it as a public case until they authorise it.

We put it exactly that way in the first meeting. A vendor who implies a customer base it does not have has already lied about the easiest thing to check, and in healthcare that costs you on the next question.

What we do put on the table is the product running on your data in 3 weeks, the full measurement methodology, and the denominator we use, written down before anyone looks at the first number: how we measure it.

We also put the full contact policy on the table: how many times the agent writes, at what hours, when it stops, and what it never says. An ethics committee or a patient-experience team can read all of it before approving the pilot, in how the agent decides.

Who will be sitting in your rollout?

The two of us. During onboarding the founders do the schedulers' job: we read orders, find slots, book appointments and disposition the outcomes. We answer in under 1 hour between 6am and 11pm, in a WhatsApp group with your team.

That way of working is the concrete advantage we hold over a competitor with 7 years in the market, and it is described week by week in how we work. That page also says when it stops scaling.

What will you not find on this page?

Four things, and every absence is deliberate.

• A logo wall. The strong logos we have belong to another company on the team, and several of those customers sit under confidentiality agreements we are not going to stretch in order to sell.
• Hands-on clinical operations experience. Neither of us spent 7 years booking exams, and whoever did that at your institution will notice in week 1. That is why your team dictates the rules and the agent executes them: you set the limits.
• Numbers with no derivation. If a percentage appears on this site, there is a published methodology and a declared denominator behind it: this is how we measure.
• Impossible integration requirements. We start from a file your institution controls and connect properly when your IT department is ready: it works without an API.

The criterion behind all four absences is the same: every sentence on this page has to survive your compliance team reading it without us in the room. Whatever fails that test collapses in the second meeting, once an expectation is built and a pilot is half assembled.

Who are you, formally?

Surface is a product of Superposition Labs, Inc., incorporated in Dover, Delaware, in December 2025, with operations in Chile. We are backed by Platanus Ventures, which invests in technical founders across Latin America.

The founders are Pablo Díaz and Víctor Perl. We link the profiles so you can verify the rest yourself, which is worth more than a credential list written by us.

The question that follows this one is almost always who owns the data and which brand the patient sees on screen. That is answered in your brand, your data, and the rest of the frequent questions in the FAQ.

And if this does not work?

A 3-week pilot answers that with your own data and an agreed control group. If the number does not move, you will see it on the same dashboard we do, the same day we do. That is also a way of saying who we are.